TrialClinical cancer research : an official journal of the American Association for Cancer Research2026
Gemcitabine plus Nivolumab with Carboplatin or Oxaliplatin in Cisplatin-Ineligible Patients with Metastatic Urothelial Carcinoma: A Randomized Phase II Trial.
Ziao Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.